Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Deoxycholic acid - Kythera Biopharmaceuticals

Next Previous
Drug Profile

Deoxycholic acid - Kythera Biopharmaceuticals

Alternative Names: ATX-101-Kythera; Belkyra; BelkyraTM; Kybella; Sodium deoxycholate; Sodium desoxycholate

Latest Information Update: 04 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Kythera Biopharmaceuticals
  • Developer Bayer Dermatology; Kythera Biopharmaceuticals
  • Class Choleretics; Cholic acids; Gallstone therapies; Small molecules
  • Mechanism of Action Cell membrane modulators; Membrane lipid modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Subcutaneous fat disorders
  • No development reported Lipoma

Most Recent Events

  • 04 Dec 2025 Deoxycholic acid is still in registered phase for Subcutaneous fat disorder in Cyprus, Slovenia, Germany, Belgium, Luxembourg, Malta, France, Italy, Greece, Slovakia (SC)
  • 12 May 2025 Launched for Subcutaneous fat disorders in Portugal, Ireland (SC)
  • 24 Sep 2021 Launched for Subcutaneous fat disorders in Sweden, United Kingdom, Spain, Denmark, New Zealand, Switzerland, Netherlands, Norway, Norway, Poland, Czech Republic, Hungary, Finland, Hong Kong, Australia, Brazil, Canada (SC) before September 2021

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top